| Pharmaceutical Information |
| Drug Name |
Iloprost |
| Drug ID |
BADD_D01135 |
| Description |
Iloprost is a synthetic analogue of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH). |
| Indications and Usage |
Used for the treatment of pulmonary arterial hypertension. |
| Marketing Status |
approved; investigational |
| ATC Code |
B01AC11 |
| DrugBank ID |
DB01088
|
| KEGG ID |
D02721
|
| MeSH ID |
D016285
|
| PubChem ID |
5311181
|
| TTD Drug ID |
D05ZTH
|
| NDC Product Code |
66215-303; 40016-013; 82231-109; 54893-0017; 66215-302 |
| UNII |
JED5K35YGL
|
| Synonyms |
Iloprost | Ciloprost | ZK-36374 | ZK 36374 | ZK36374 | Ventavis |
|
| Chemical Information |
| Molecular Formula |
C22H32O4 |
| CAS Registry Number |
78919-13-8 |
| SMILES |
CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
